VBL Therapeutics Announces Year End 2017 Financial Results
Mar 15, 2018 11:15 am UTC| Business
Conference Call and Webcast at 8:30am Eastern Time TEL AVIV, Israel, March 15, 2018 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Triumph Motorcycles Revs Up B2C, B2B eCommerce with Website Redesign by Bridgeline Digital
Mar 15, 2018 11:09 am UTC| Business
BURLINGTON, Mass., March 15, 2018 -- Bridgeline Digital, Inc. (NASDAQ:BLIN), a provider in cloud-based Web Content Management, eCommerce and Marketing Automation software, announced today the launch of a newly...
Aptose to Present New CG’806 and APTO-253 Data at the 2018 AACR Annual Meeting
Mar 15, 2018 11:05 am UTC| Business
SAN DIEGO and TORONTO, March 15, 2018 -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying...
BigRentz Sees Significant Change in Rental Behavior With Touchless Bookings Process
Mar 15, 2018 11:03 am UTC| Business
Bookings completed entirely online grew to over 30% of all transactions; Company offers discounted hauling fees for all online orders IRVINE, Calif., March 15, 2018 -- BigRentz, the nation’s largest equipment rental...
Asanko Gold Reports Q4 and Full Year 2017 Results, Provides 2018 Guidance and a 5-Year Outlook
Mar 15, 2018 11:01 am UTC| Business
VANCOUVER, British Columbia, March 15, 2018 -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX:AKG) (NYSE American:AKG) reports its fourth quarter (“Q4”) and full year (“FY”) 2017 operating and financial results, as...
Mar 15, 2018 11:01 am UTC| Business
TORONTO, March 15, 2018 -- Snipp Interactive Inc. ("Snipp" or the “Company”) (OTCQB:SNIPF) (TSX-V:SPN), a global provider of digital marketing promotions, rebates and loyalty solutions, shared their perspective with...
Mar 15, 2018 11:01 am UTC| Business
BERKELEY HEIGHTS, N.J., March 15, 2018 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases...